Midostaurin for Acute Myeloid Leukaemia (AML)

What's in this booklet? 

Midostaurin is a multi-targeted protein kinase inhibitor. Midostaurin has been approved for the treatment of adult patients with AML.

This hardcopy version of our booklet can be ordered free of charge to UK addresses.